Family history of stroke is potentially associated with arterial stiffness in the Japanese population  by Uemura, Hirokazu et al.
AC
F
a
J
U
a
v
p
1rchives of Cardiovascular Disease (2014) 107, 654—663
Available  online  at
ScienceDirect
www.sciencedirect.com
LINICAL RESEARCH
amily  history  of  stroke  is  potentially
ssociated  with  arterial  stiffness  in  the
apanese  population
n  antécédent  familial  d’infarctus  cérébral  est  potentiellement
ssocié  avec  la  rigidité  artérielle  dans  une  population  japonaise
Hirokazu  Uemuraa,∗,  Sakurako  Katsuura-Kamanoa,
Miwa  Yamaguchia,  Mariko  Nakamotob,
Mineyoshi  Hiyoshia,  Kokichi  Arisawaa
a Department  of  Preventive  Medicine,  Institute  of  Health  Biosciences,  The  University  of
Tokushima  Graduate  School,  3-18-15,  Kuramoto-cho,  770-8503  Tokushima,  Japan
b Department  of  Public  Health  and  Applied  Nutrition,  Institute  of  Health  Biosciences,
The University  of  Tokushima  Graduate  School,  Tokushima,  Japan
Received  18  April  2014;  accepted  1st  July  2014
Available  online  16  September  2014
KEYWORDS
Vascular  stiffness;
Stroke;
Cross-sectional
studies
Summary
Background.  —  Studies  on  the  association  between  family  history  of  cardiovascular  disease  and
arterial stiffness  are  rare.
Aims.  —  This  study  evaluated  the  possible  relationship  between  family  history  of  cardiovascular
disease and  arterial  stiffness  in  the  Japanese  population,  by  measuring  brachial-ankle  pulse
wave velocity  (ba-PWV).
Methods.  —  A  total  of  1004  eligible  subjects  (664  men  and  340  women)  aged  35—69  years,
who were  enrolled  in  the  baseline  survey  of  a  cohort  study  in  Tokushima  Prefecture  (Japan)
and who  underwent  ba-PWV  measurement,  were  analysed.  Information  about  their  lifestyle
characteristics  and  ﬁrst-degree  family  histories  of  ischaemic  heart  disease  (i.e.  myocardial
infarction  or  angina  pectoris),  stroke  or  hypertension  were  obtained  from  a  structural  self-
administered  questionnaire.
Abbreviations: ABI, ankle-brachial pressure index; ba-PWV, brachial-ankle pulse wave velocity; cf-PWV, carotid-femoral pulse wave
elocity; HDL, high-density lipoprotein; J-MICC, Japan Multi-Institutional Collaborative Cohort; MET, metabolic equivalent of task; PWV,
ulse wave velocity.
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Results.  —  Subjects  of  both  sexes  with  a  family  history  of  stroke  showed  signiﬁcantly  higher
multivariable-adjusted  means  of  ba-PWV  than  those  without  that  trait  (P  values  were  0.001  in
men and  0.002  in  women),  while  those  with  a  family  history  of  ischaemic  heart  disease  did  not.
Subjects  of  both  sexes  with  a  family  history  of  hypertension  showed  signiﬁcantly  higher  age-
adjusted means  of  ba-PWV  than  those  without  that  trait,  although  these  differences  disappeared
after further  adjusting  for  blood  pressure  or  multivariable  covariates.  When  family  histories  of
these diseases  were  inserted  simultaneously  into  the  same  model,  these  results  did  not  alter
substantially.
Conclusion.  —  A  family  history  of  stroke  might  be  associated  with  increased  arterial  stiffness,
independent  of  other  known  atherosclerotic  risk  factors,  including  hypertensive  elements,  in
both sexes  in  the  Japanese  population.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Justiﬁcation.  —  Les  études  sur  les  associations  entre  les  antécédents  familiaux  de  maladie
cardiovasculaire  et  la  rigidité  artérielle  sont  rares.
Objectifs.  —  Cette  étude  a  évalué  la  possible  relation  entre  les  antécédents  familiaux  de  mal-
adie cardiovasculaire  et  la  rigidité  artérielle  au  sein  d’une  population  japonaise,  en  mesurant
le paramètre  vélocité  de  l’onde  de  pouls  bras-cheville.
Méthode.  — Mille  quatre  sujets  éligibles  (664  hommes)  âgés  de  35  à  69  ans,  ont  été  inclus  au
sein de  cette  cohorte  de  la  préfecture  de  Tokushima  au  Japon  et  ont  bénéﬁcié  d’une  mesure
de la  vélocité  de  l’onde  de  pouls  bras-cheville,  paramètre  qui  a  été  analysé.  L’information
concernant  les  caractéristiques  de  base,  le  mode  de  vie,  les  antécédents  familiaux  de  maladie
coronaire  de  1er degré  (infarctus  du  myocarde  ou  angine  de  poitrine),  d’infarctus  cérébral  et
d’hypertension  artérielle  ont  été  obtenus  à  partir  d’un  questionnaire  structuré  renseigné  par
les patients.
Résultats.  — Les  sujets  des  deux  sexes  ayant  un  antécédent  familial  d’infarctus  cérébral  avaient
des moyennes  de  vélocité  de  l’onde  de  pouls  bras-cheville  dans  les  deux  sexes  signiﬁcativement
plus élevées  (p  =  0,001  chez  l’homme  et  p  =  0,002  chez  la  femme),  comparativement  aux  sujets
n’ayant pas  de  tels  antécédents,  tandis  que  les  patients  ayant  un  antécédent  familial  de  car-
diopathie ischémique  n’avaient  pas  de  différence  signiﬁcative  concernant  ce  paramètre.  Les
sujets des  deux  sexes  ayant  un  antécédent  familial  d’hypertension  artérielle  avaient  égale-
ment des  valeurs  moyennes  de  cet  indice  plus  élevées,  comparativement  aux  sujets  n’ayant
pas ce  trait,  mais  ces  différences  n’étaient  plus  signiﬁcatives  après  ajustement  sur  la  pression
artérielle  ou  sur  les  co-variables  en  analyse  multivariée.  Lorsque  les  antécédents  familiaux
de ces  affections  cérébro-vasculaires  et  ischémiques  étaient  inclus  dans  le  même  modèle,  ces
résultats n’étaient  pas  modiﬁés  de  fac¸on  signiﬁcative.
Conclusion.  —  Un  antécédent  familial  d’infarctus  cérébral  pourrait  être  potentiellement  associé
avec une  augmentation  de  la  rigidité  artérielle,  indépendamment  des  autres  facteurs  de  risque
d’athérosclérose  connus,  hypertension  artérielle  en  particulier,  et  ce  dans  les  deux  sexes,  dans
une population  japonaise.
©  2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Cardiovascular  events  are  major  causes  of  death  worldwide.
Atherosclerosis  is  the  main  factor  leading  to  cardiovascular
events.  Arterial  stiffness  is  an  indicator  of  atheroscle-
rotic  vascular  change  and  can  be  assessed  by  measuring
pulse  wave  velocity  (PWV)  [1].  Many  epidemiological  stud-
ies  have  reported  positive  associations  between  PWV  and
the  development  of  atherosclerotic  disease  [2,3].  PWV
is  recognized  as  a  marker  of  the  severity  of  vascular
damage  [4];  moreover,  it  is  a  predictor  of  cardiovascular
events  [5]  and  mortality  [6].  Brachial-ankle  PWV  (ba-PWV)
m
h
aan  be  measured  conveniently  and  non-invasively,  and  is
seful  for  evaluating  the  early  stages  of  atherosclerosis
7,8].
Mortality  due  to  ischaemic  heart  disease  is  less  frequent
n  Japan  than  in  Western  countries  [9].  However,  mortality
nd  morbidity  due  to  stroke  are  more  frequent  in  Japan,
specially  in  men  [9].  Recent  studies  have  revealed  that
ncreased  PWV  is  associated  with  coronary  and  cerebral
therosclerosis  [10,11]. Family  history  is  a risk  factor  for
any  chronic  diseases,  including  hypertension,  ischaemic
eart  disease  and  stroke  [12,13].  However,  little  is  known
bout  the  inﬂuence  of  family  history  of  cardiovascular
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a56  
isease  on  arterial  stiffness.  Therefore,  this  study  evalu-
ted  the  possible  relationship  between  a  family  history  of
schaemic  heart  disease,  stroke  or  hypertension  and  arterial
tiffness  in  the  Japanese  population.
ethods
tudy subjects
 total  of  1065  participants  aged  35—69  years,  who  were
nrolled  in  the  baseline  survey  of  a  prospective  cohort  study
n  Tokushima  Prefecture  (Japan),  and  who  underwent  mea-
urement  of  ba-PWV  and  serum  lipid  concentration  at  the
aseline  survey  from  November  2009  to  June  2012  were
ncluded  in  this  cross-sectional  study.  This  cohort  study
as  performed  as  part  of  the  prospective  cohort  study
the  Japan  Multi-Institutional  Collaborative  Cohort  [J-MICC]
tudy),  as  described  previously  [14].  Brieﬂy,  the  aim  of  the
-MICC  Study  is  to  examine  the  associations  of  lifestyle  and
enetic  factors  and  their  interactions  with  lifestyle-related
iseases.  All  participants  in  the  J-MICC  Study  provided
ritten  informed  consent.  The  ethics  committees  of  the
agoya  university  school  of  medicine  (the  afﬁliation  of  the
ormer  principal  investigator  [Nobuyuki  Hamajima]),  the
ichi  cancer  centre  (the  afﬁliation  of  the  current  principal
nvestigator  [Hideo  Tanaka])  and  the  university  of  Tokushima
raduate  school  approved  the  protocol  of  this  study.
uestionnaire
e  obtained  information  on  individual  lifestyle  characteris-
ics  for  the  past  year  through  a  structural  self-administered
uestionnaire;  all  the  responses  were  reviewed  by  trained
taff  at  the  time  of  the  survey.  Leisure-time  exercise  was
stimated  based  on  the  International  Physical  Activity  Ques-
ionnaire  [15].  Exercise  was  divided  into  three  levels:  light
xercise,  such  as  walking  or  hiking;  moderate  exercise,
uch  as  light  jogging  or  swimming;  and  vigorous  exercise,
uch  as  marathon  running  or  competitive  sports.  Degrees  of
eisure-time  exercise  for  the  three  levels  were  expressed
s  metabolic  equivalent  of  task  (MET)-hours/week  (MET
evel  ×  hours  of  activity  ×  events  per  week)  and  summed
16].  In  this  estimation,  3.4  METs  were  assigned  for  light
xercise,  7.0  METs  for  moderate  exercise  and  10.0  METs  for
igorous  exercise.  Body  height  was  obtained  from  the  ques-
ionnaire;  body  weight  was  measured  to  the  nearest  0.1  kg
t  the  survey.  Body  mass  index  was  calculated  as  weight  (in
ilograms)  divided  by  height  (in  meters)  squared.  Addition-
lly,  we  obtained  information  regarding  ﬁrst-degree  family
istories  of  ischaemic  heart  disease,  including  myocardial
nfarction  or  angina  pectoris,  stroke  and  hypertension  (i.e.
ositive,  negative  or  unknown).  When  analysed,  a  response
f  ‘positive’  was  regarded  as  having  a  family  history  of  the
isease,  whereas  ‘negative’  and  ‘unknown’  were  regarded
s  not  having  a  family  history  of  the  disease.
ulse wave velocity and biochemical
easurements
a-PWV  was  measured  using  a  waveform  analyser  (model
P-203RPE  III;  Colin,  Co.  Ltd.,  Komaki,  Japan),  as  described
s
H
d
eH.  Uemura  et  al.
reviously  [17].  Brieﬂy,  the  subjects  were  examined  while
esting  in  the  supine  position  in  an  air-conditioned  room.
xtremity  blood  pressure  was  measured  using  an  oscillomet-
ic  method  and  the  ankle-brachial  pressure  index  (ABI)  was
utomatically  calculated.  Heart  rate  was  recorded  simulta-
eously.  ba-PWV  was  calculated  using  time-phase  analysis
etween  the  right  brachial  artery  pressure  and  volume
aveforms  at  both  ankles.  To  reduce  interobserver  vari-
tion,  all  ba-PWV  measurements  were  performed  by  one
esearcher  throughout  the  study.  Individual  ba-PWV  and  ABI
ata  are  expressed  as  the  mean  of  the  bilateral  ba-PWV
nd  ABI,  respectively.  Venous  blood  was  aspirated  from  each
articipant  and  serum  was  separated  within  3  hours.  Serum
ipid  concentrations  were  measured  at  an  external  labora-
ory  (BML  Inc.,  Tokyo,  Japan).
tatistical analyses
mong  the  1065  participants  (710  men  and  355  women)  ini-
ially  included  in  this  cross-sectional  study,  we  excluded
4  with  a  history  of  ischaemic  heart  disease  (n  =  21)  and
troke  (n  =  16).  We  excluded  another  ﬁve  subjects  who  had
 low  right  or  left  ABI  (ABI  ≤  0.9),  which  suggested  that
hey  might  have  had  peripheral  arterial  occlusive  disease.
here  were  no  subjects  who  self-reported  a  history  of  cir-
hosis  or  hepatic  cancer.  We  further  excluded  subjects  with
issing  data  on  family  history  of  cardiovascular  diseases
n  = 10).  After  excluding  an  additional  12  subjects  for  whom
erum  lipid  concentration  data  were  missing,  1004  subjects
664  men  and  340  women)  were  ﬁnally  included  in  the
nalyses.
Continuous  variables  are  expressed  as  mean  ±  standard
eviation  or  median  (25  percentile,  75  percentile).
ategorical  variables  are  expressed  as  proportion  (%).
tudent’s  t  test,  Wilcoxon  rank-sum  test  and  Fisher’s
xact  test  were  used  to  compare  baseline  characteristics
etween  subjects  with  and  without  a  family  history  of
iseases.
Prevalent  hypertension  was  deﬁned  as  systolic  blood
ressure  ≥  140  mmHg  or  diastolic  blood  pressure  ≥  90  mmHg
r  receiving  antihypertensive  treatment.  Hypercholestero-
aemia  was  deﬁned  as  serum  total  cholesterol  ≥  220  mg/dL
r  receiving  treatment  for  hypercholesterolaemia,  and  low
igh-density  lipoprotein  (HDL)  cholesterol  was  deﬁned  as
erum  HDL  cholesterol  <  40  mg/dL.  Elevated  triglycerides
ere  deﬁned  as  serum  triglycerides  ≥  150  mg/dL.  Prevalent
iabetes  was  deﬁned  as  having  a  history  of  diabetes.  We
sed  general  linear  models  to  evaluate  the  associations  of
amily  histories  of  ischaemic  heart  disease,  stroke  or  hyper-
ension  with  ba-PWV  values  in  men  and  women  separately,
fter  adjusting  for  the  probable  covariates.  Adjusted  covari-
tes  were  as  follows:  age  (continuous)  (model  1);  age  and
ystolic  blood  pressure  (<  120,  120  to  <  140,  140  to  <  160,
 160  mmHg  without  treatment  and  receiving  antihyperten-
ive  treatment)  (model  2);  age,  systolic  blood  pressure,  body
ass  index  (kg/m2) (sex-speciﬁc  quartiles),  smoking  status
current,  past  and  never),  alcohol  drinking  (current,  past
nd  never),  leisure-time  exercise  (MET  hours/week)  (sex-
peciﬁc  quartiles),  hypercholesterolaemia  (no/yes),  low
DL  cholesterol  (no/yes),  elevated  triglycerides  (no/yes),
iabetes  (no/yes)  and  heart  rate  (continuous),  with  experi-
nced  menopause  (no/yes)  included  for  women  (model  3).
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sFamily  history  of  stroke  and  arterial  stiffness  
We  further  evaluated  the  associations  of  family  histories  of
ischaemic  heart  disease,  stroke  or  hypertension  with  ba-
PWV  values  in  additional  models;  family  histories  of  these
diseases  were  inserted  simultaneously  into  the  models,  to
avoid  their  overlapping  inﬂuences,  adjusting  for  age  (model
4),  age  and  systolic  blood  pressure  (model  5)  and  the  same
covariates  as  in  model  3  (model  6).
All  statistical  tests  were  based  on  two-sided  probabilities
performed  using  SAS  version  8.2  (SAS  Institute  Inc.,  Cary,  NC,
USA).  The  level  of  statistical  signiﬁcant  was  set  at  P  <  0.05.
Results
Baseline characteristics
Age  was  signiﬁcantly  correlated  with  ba-PWV  in  both
sexes  (r  =  0.492,  P  <  0.001  in  men  and  r  =  0.534,  P  <  0.001  in
women).  Systolic  blood  pressure  was  also  strongly  correlated
with  ba-PWV  in  both  sexes  (r  =  0.646,  P  <  0.001  in  men  and
r  =  0.770,  P  <  0.001  in  women).  There  were  no  signiﬁcant
differences  between  sexes  in  the  proportions  with  family
histories  of  ischaemic  heart  disease,  stroke  or  hypertension
(data  not  shown).
Tables  1  and  2  show  the  characteristics  of  the  subjects
with  and  without  family  histories  of  ischaemic  heart  disease,
stroke  or  hypertension  in  men  and  women,  respectively.  Men
had  considerably  higher  ba-PWV  values  than  women.  Sub-
jects  of  both  sexes  with  a  family  history  of  ischaemic  heart
disease  or  stroke  were  older  than  those  without  such  a fam-
ily  history.  Subjects  of  both  sexes  with  a  family  history  of
stroke  or  hypertension  had  signiﬁcantly  higher  systolic  blood
pressure  and  higher  prevalence  of  hypertension  than  those
without  such  a  family  history,  while  those  with  a  family  his-
tory  of  ischaemic  heart  disease  did  not.  Subjects  of  both
sexes  with  a  family  history  of  stroke  or  hypertension  showed
signiﬁcantly  higher  ba-PWV  values  than  those  without  such
a  family  history.  Women  with  a  family  history  of  ischaemic
heart  disease  had  signiﬁcantly  higher  ba-PWV  values  than
those  without  that  trait,  while  men  with  a  family  history  of
ischaemic  heart  disease  did  not.
Association between family history of
cardiovascular disease and arterial stiffness
Sex-speciﬁc  analyses  (Table  3)  revealed  that  subjects  of  both
sexes  with  a  family  history  of  stroke  had  signiﬁcantly  higher
age-adjusted,  age  and  systolic  blood  pressure-adjusted  and
multivariable-adjusted  means  of  ba-PWVs  than  those  with-
out  such  a  family  history  (models  1,  2  and  3),  while  subjects
of  both  sexes  with  a  family  history  of  ischaemic  heart  dis-
ease  did  not.  Subjects  of  both  sexes  with  a  family  history
of  hypertension  showed  signiﬁcantly  higher  age-adjusted
means  of  ba-PWVs  than  those  without  that  trait  (model  1),
although  these  differences  disappeared  in  age  and  systolic
blood  pressure-adjusted  and  multivariable-adjusted  models
(models  2 and  3).  These  results  did  not  substantially  alter
when  family  histories  of  these  diseases  were  inserted  simul-
taneously  into  the  same  models  (models  4,  5  and  6)  (Table  4).
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n  this  study,  we  investigated  that  having  a  family  history
f  stroke  was  potentially  associated  with  increased  ba-PWV
n  Japanese  men  and  women,  independent  of  other  well-
nown  atherosclerotic  risk  factors  including  hypertensive
lements.
Carotid-femoral  PWV  (cf-PWV)  is  an  established  index
or  assessing  aortic  stiffness;  its  values  are  well  correlated
ith  vascular  damage  [4]. However,  measuring  cf-PWV  is
ather  complicated  and  time  consuming.  Meanwhile,  ba-
WV  measurement  is  convenient  and  only  requires  a  short
ime.  The  ba-PWV  reﬂects  the  arterial  stiffness  of  both
arge  and  mid-sized  arteries  such  as  the  aorta  and  arter-
es  of  the  lower  limbs  [7,17];  however,  it  is  well  correlated
ith  cf-PWV  as  well  as  aortic  PWV  assessed  using  a  direct
atheter  method  [7].  Therefore,  ba-PWV  measurement  is
seful  for  screening  arterial  atherosclerotic  changes  in  large
opulations.  Aging  was  strongly  associated  with  increased
a-PWV  in  both  sexes,  which  is  concordant  with  previous
tudies  [17].  Furthermore,  ba-PWV  was  higher  in  men  than
n  women,  which  is  consistent  with  other  reports  [17,18].
ome  studies  have  demonstrated  that  oestrogen  has  protec-
ive  effects  against  increased  arterial  stiffness  [19].
Cohort  studies  have  revealed  that  increased  PWV  is  asso-
iated  with  an  increased  incidence  of  stroke  in  the  general
opulation  after  adjusting  for  other  known  cardiovascular
isk  factors  [20,21].  In  addition,  increased  arterial  stiffness
ay  predict  cerebrovascular  events  through  an  increased
entral  brachial  pulse  pressure  [22]. According  to  these
eports,  there  should  be  a  close  association  between  stroke,
hich  has  familial  inheritance,  and  increased  ba-PWV.  How-
ver,  studies  on  the  impact  of  family  history  of  stroke  on
a-PWV  are  rare.  Moreover,  mortality  and  morbidity  due
o  stroke  are  frequent  in  Japan,  especially  in  men  [9].
herefore,  we  evaluated  the  relationship  between  family
istory  of  stroke,  ischaemic  heart  disease  or  hypertension
nd  arterial  stiffness  in  the  Japanese  population.  In  addi-
ion  to  age  and  sex,  blood  pressure  is  a  well-recognized
eterminant  of  ba-PWV  [23].  In  this  study,  we  conﬁrmed
hat  systolic  blood  pressure  is  strongly  correlated  with  ba-
WV  in  both  sexes  (r  =  0.646,  P  <  0.001  in  men  and  r  = 0.770,
 <  0.001  in  women).  Increased  blood  pressure  and  arterial
tiffness  may  be  associated  with  each  other.  Age-adjusted
ssociations  were  found  between  a  family  history  of  hyper-
ension  and  increased  ba-PWV  in  both  sexes,  although  these
ssociations  disappeared  after  further  adjustment  for  sys-
olic  blood  pressure  and  multivariable  covariates,  including
lood  pressure.  The  ﬁndings  suggest  that  hypertensive  ele-
ents  may  largely  contribute  to  the  relationship  between  a
amily  history  of  hypertension  and  increased  ba-PWV.  By  con-
rast,  we  observed  the  age-adjusted,  age  and  systolic  blood
ressure-adjusted  and  multivariable-adjusted  associations
etween  a  family  history  of  stroke  and  increased  ba-PWV
n  both  sexes;  these  adjusted  associations  did  not  substan-
ially  alter  when  family  histories  of  ischaemic  heart  disease,
troke  or  hypertension  were  inserted  simultaneously  into  the
ame  models.  Therefore,  a  family  history  of  stroke  itself
ay  contribute  considerably  to  an  increased  ba-PWV,  inde-
endent  of  other  well-known  atherosclerotic  risk  factors,
ncluding  hypertensive  elements,  in  both  sexes.  Conven-
ional  cardiovascular  risk  factors,  such  as  hypertension,
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Table  1  Baseline  characteristics  of  subjects  with  and  without  family  history  of  ischaemic  heart  disease,  stroke  or  hypertension  in  men.
Family  history
Ischaemic  heart  disease  Stroke  Hypertension
No
(n  =  541;
81.5%)
Yes
(n =  123;
18.5%)
P No
(n  =  558;
84.0%)
Yes
(n =  106;
16.0%)
P No
(n  =  343;
51.7%)
Yes
(n =  321;
48.3%)
P
Age  (years)  48.5  ±  8.6  50.6  ±  8.3  0.013  48.4  ±  8.5  51.8  ±  8.4  <  0.001  48.3  ±  8.6  49.5  ±  8.6  0.070
Body  mass  index  (kg/m2)  24.5  ±  3.4  24.5  ±  3.2  0.920  24.6  ±  3.5  24.0  ±  2.7  0.081  24.4  ±  3.5  24.6  ±  3.2  0.553
Smoking  status
Never  30.3  27.6  30.1  28.3  28.9  30.8
Past  34.9  41.5  0.413  34.2  46.2  0.044  36.2  36.1  0.827
Current  34.8  30.9  35.7  25.5  35  33
Alcohol  drinking
Never  26.1  17.9  24.7  23.6  26.5  22.4
Past  1.8  0.8  0.111  1.6  1.9  0.882  1.2  2.2  0.308
Current  72.1  81.3  73.7  74.5  72.3  75.4
Exercise  (MET-hours/week)  3.9  (0.4,  14.0)  5.6  (1.3,  15.3)  0.156  3.9  (0.4,  14.0)  7.7  (2.6,  17.9)  0.002  4.3  (0.4,  15.3)  5.1  (1.3,  15.3)  0.316
Systolic  BP  (mmHg)  134.1  ±  16.2  137.1  ±  17.7  0.069  134.1  ±  16.3  137.8  ±  17.6  0.036  132.4  ±  15.2  137.1  ±  17.6  <  0.001
Diastolic  BP  (mmHg)  84.0  ±  11.3  85.5  ±  11.3  0.183  84.0  ±  11.2  85.8  ±  11.6  0.137  82.7  ±  10.8  86.0  ±  11.6  <  0.001
Heart  rate  (beats/min)  66.8  ±  10.1  68.5  ±  12.2  0.152  67.3  ±  10.6  66.2  ±  10.2  0.327  66.5  ±  10.2  67.8  ±  10.9  0.108
Total  cholesterol  (mg/dL)  211.8  ±  35.0  212.5  ±  31.1  0.839  212.3  ±  34.5  210.4  ±  33.2  0.598  210.3  ±  34.8  213.7  ±  33.7  0.198
HDL  cholesterol  (mg/dL)  56.2  ±  11.9  56.8  ±  11.9  0.572  56.3  ±  11.9  56.4  ±  12.0  0.934  55.8  ±  12.3  56.8  ±  11.4  0.305
Triglycerides  (mg/dL)  111  (75,  164)  106  (77,  148)  0.575  107  (75,  155)  117.5  (84,  172)  0.029  111  (74,  165)  107  (79,  155)  0.923
Prevalence
Hypertension  44.2  53.7  0.071  43.9  56.6  0.019  38.8  53.6  <  0.001
Hypercholesterolaemia  40.3  43.9  0.478  41.4  38.7  0.667  39.7  42.4  0.479
Low  HDL  cholesterol  4.8  4.9  1.000  4.3  7.6  0.211  6.7  2.8  0.028
Elevated  triglycerides  29.9  23.6  0.186  27.4  35.9  0.081  30.6  26.8  0.304
Diabetes  3.9  7.3  0.144  4.7  3.8  1.000  4.4  4.7  0.854
ABI  1.12  ±  0.06  1.13  ±  0.06  0.138  1.12  ±  0.07  1.14  ±  0.06  <  0.001  1.12  ±  0.07  1.13  ±  0.06  0.045
ba-PWV  (cm/s)  1432  ±  229  1466  ±  268  0.193  1419  ±  220  1537  ±  293  <  0.001  1409  ±  217  1468  ±  253  0.001
Data are mean ± standard deviation, % or median (25th percentile, 75th percentile). ABI: ankle-brachial pressure index; ba-PWV: brachial-ankle pulse wave velocity; BP: blood pressure;
HDL: high-density lipoprotein; MET: metabolic equivalent of task.
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Table  2 Baseline  characteristics  of  subjects  with  and  without  family  history  of  ischaemic  heart  disease,  stroke  or  hypertension  in  women.
Family  history
Ischaemic  heart  disease Stroke  Hypertension
No
(n  =  269;
79.1%)
Yes
(n =  71;
20.9%)
P No
(n  =  295;
86.8%)
Yes
(n =  45;
13.2%)
P  No
(n  =  168;
49.4%)
Yes
(n  =  172;
50.6%)
P
Age  (years) 46.1  ±  7.5 49.4  ±  7.3 0.001 46.2  ±  7.3 50.8  ±  8.3 <  0.001 46.0  ±  7.3 47.5  ±  7.7 0.061
Body  mass  index  (kg/m2) 21.7  ±  3.2 22.4  ±  3.4 0.083 21.8  ±  3.2 22.1  ±  3.2 0.558  21.5  ±  3.0 22.1  ±  3.4 0.080
Smoking  status
Never  88.5  84.5  87.5  88.9  86.9  88.4
Past 5.6  12.7  0.097 7.1  6.7  1.000  6.5  7.6  0.561
Current  5.9  2.8  5.4  4.4  6.5  4.1
Alcohol  drinking
Never  56.5  50.7  55.6  53.3  58.3  52.3
Past 1.9  1.4  0.744 1.7  2.2  0.842  1.2  2.3  0.437
Current  41.6  47.9  42.7  44.4  40.5  45.4
Exercise  (MET-hours/week) 2.2  (0,  9.1) 2.1  (0,  6.8) 0.243 1.5  (0,  7.8) 3.0  (0.4,  11.6) 0.236  2.6  (0,  12.8) 2.6  (0.4,  7.7)  0.824
Systolic  BP  (mmHg) 123.8  ±  17.6 126.8  ±  20.0 0.207 122.9  ±  16.4 134.0  ±  25.2 0.006  120.4  ±  15.6 128.3  ±  19.6 <  0.001
Diastolic  BP  (mmHg) 74.8  ±  11.8 77.1  ±  11.7 0.150 74.4  ±  11.0 80.8  ±  15.0 0.008  73.2  ±  11.0 77.3  ±  12.2 0.001
Heart  rate  (beats/min) 69.0  ±  12.9 66.4  ±  7.8 0.032 68.7  ±  12.6 66.9  ±  7.8 0.181  68.6  ±  14.8 68.4  ±  8.7 0.877
Total  cholesterol  (mg/dL) 212.0  ±  36.5 217.0  ±  37.3 0.307 211.6  ±  35.9 222.5  ±  40.9 0.063  208.3  ±  34.1 217.7  ±  38.6 0.018
HDL  cholesterol  (mg/dL) 69.1  ±  13.4 66.4  ±  12.7 0.139 68.6  ±  13.6 67.8  ±  11.2 0.713  68.4  ±  13.4 68.6  ±  13.2 0.874
Triglycerides  (mg/dL) 67  (51,  101) 80  (53,  108) 0.089 68  (50,  101) 80  (58,  112) 0.110  66  (49.5,  100) 72.5  (52,  109.5) 0.173
Prevalence
Hypertension  19.7  25.4  0.325 18.3  37.8  0.005  14.3  27.3  0.003
Hypercholesterolaemia  41.3  47.9  0.346 41.7  48.9  0.419  42.3  43.0  0.913
Low  HDL  cholesterol 0.7  1.4  0.506 1.0  0.0  1.000  0.6  1.2  1.000
Elevated  triglycerides 10.8  12.7  0.673 11.5  8.9  0.800  9.5  12.8  0.391
Diabetes  0.7  0.0  1.000 0.3  2.2  0.248  0.0  1.2  0.499
ABI  1.08  ±  0.07 1.08  ±  0.06 0.548 1.08  ±  0.07 1.09  ±  0.06 0.198  1.09  ±  0.07 1.08  ±  0.07 0.330
ba-PWV  (cm/s) 1247  ±  216 1316  ±  245 0.021 1238  ±  196 1414  ±  322 <  0.001 1224  ±  183 1298  ±  253 0.002
Data are mean ± standard deviation, % or median (25th percentile, 75th percentile). ABI: ankle-brachial pressure index; ba-PWV: brachial-ankle pulse wave velocity; BP: blood pressure;
HDL: high-density lipoprotein; MET: metabolic equivalent of task.
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Table  3  Associations  between  family  history  of  cardiovascular  disease  and  brachial-ankle  pulse  wave  velocity  values  by  analysis  of  covariance.
n  %  Model  1a ba-PWV  values  (cm/s)  Model  2b ba-PWV  values  (cm/s)  Model  3c ba-PWV  values  (cm/s)
Adjusted
mean
SE  P  Adjusted
mean
SE  P  Adjusted
mean
SE P
Men
Family  history  of  ischaemic  heart  disease
No  541  81.5  1437  9  0.802  1476  9  0.608  1476  27  0.376
Yes  123  18.5  1442  19  1467  16  1461  30
Family  history  of  stroke
No  558  84.0  1426  9  <  0.001  1465  8  0.003  1462  27  0.001
Yes  106  16.0  1499  20  1521  17  1522  30
Family  history  of  hypertension
No  343  51.7  1417  11  0.008  1467  10  0.266  1466  27  0.266
Yes  321  48.3  1460  11  1482  10  1481  27
Women
Family  history  of  ischaemic  heart  disease
No  269  79.1  1258  12  0.498  1377  12  0.623  1433  69  0.197
Yes  71  20.9  1275  23  1386  18  1458  71
Family  history  of  stroke
No  295  86.8  1247  11  <  0.001  1368  11  0.007  1417  68  0.002
Yes  45  13.2  1354  28  1430  22  1490  70
Family  history  of  hypertension
No  168  49.4  1236  15  0.016  1378  14  0.942  1428  70  0.529
Yes 172  50.6  1286  14  1379  13  1438  69
ba-PWV: brachial-ankle pulse wave velocity; SE: standard error.
a Model 1 adjusted for age.
b Model 2 adjusted for age and systolic blood pressure.
c Model 3 adjusted for age, systolic blood pressure, body mass index, smoking status, alcohol drinking, leisure-time exercise, hypercholesterolaemia, low high-density lipoprotein
cholesterol, elevated triglycerides, diabetes, heart rate and, additionally for women, menopausal status.
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Table  4 Associations  between  family  history  of  cardiovascular  disease  and  brachial-ankle  pulse  wave  velocity  when  three  family  histories  were  simultaneously
inserted  into  the  same  models.
n  %  Model  4a ba-PWV  values  (cm/s) Model  5b ba-PWV  values  (cm/s) Model  6c ba-PWV  values  (cm/s)
Adjusted
mean
SE P  Adjusted
mean
SE  P  Adjusted
mean
SE P
Men
Family  history  of  ischaemic  heart  disease
No  541  81.5 1462  12  0.666 1496  11  0.326 1497  27  0.172
Yes 123  18.5 1453  20  1479  17  1473  30
Family  history  of  stroke
No  558  84.0 1425  11  0.005 1459  10  0.004 1454  27  0.001
Yes 106  16.0 1489  21  1515  18  1516  31
Family  history  of  hypertension
No  343  51.7 1441  16  0.047 1483  14  0.589  1481  29  0.624
Yes 321  48.3 1474  14  1491  12  1488  28
Women
Family  history  of  ischaemic  heart  disease
No  269  79.1  1295  16  0.730  1398  14  0.746  1449  68  0.324
Yes  71  20.9  1304  25  1404  20  1468  70
Family  history  of  stroke
No  295  86.8  1251  13  0.002  1370  13  0.008  1423  69  0.003
Yes  45  13.2  1349  29  1432  23  1494  70
Family  history  of  hypertension
No  168  49.4  1280  21  0.053  1404  17  0.772  1456  70  0.808
Yes  172  50.6  1320  18  1399  15  1460  68
ba-PWV: brachial-ankle pulse wave velocity; SE: standard error.
a Model 4 adjusted for age.
b Model 5 adjusted for age and systolic blood pressure.
c Model 6 adjusted for age, systolic blood pressure, body mass index, smoking status, alcohol drinking, leisure-time exercise, hypercholesterolaemia, low high-density lipoprotein
cholesterol, elevated triglycerides, diabetes, heart rate and, additionally for women, menopausal status.
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moking,  hyperlipidaemia,  diabetes  and  atrial  ﬁbrillation,
re  not  able  to  account  for  all  stroke  risk  [24].  Epidemi-
logical  studies,  including  twin  studies  and  family  history
tudies,  suggest  that  genetic  predisposition  is  also  important
or  stroke  risk  [25,26].  A  number  of  genes  contributing  to
troke  have  been  discovered  by  linkage,  the  candidate-gene
pproach  and  genome-wide  association  studies.  Therefore,
enetic  predisposition  is  thought  to  be  one  mediator  for  the
ssociation  between  a  family  history  of  stroke  and  increased
rterial  stiffness.  Shared  familial  lifestyle  is  another  proba-
le  mediator  for  this  association;  however,  it  is  difﬁcult  to
eparate  this  from  genetic  risk.  Family  history  studies  have
hown  that  genetic  risk  of  stroke  may  be  stronger  for  the
arge-artery  disease  and  small-vessel  disease  subtypes  [27];
he  small-vessel  disease  subtype  (lacunar  stroke)  is  common
n  Japanese.  In  fact,  a  PRKCH  (protein  kinase  C  eta)  variant
as  been  identiﬁed  as  being  associated  with  the  small-vessel
isease  stroke  subtype  in  a  Japanese  population  [28]. For  a
apanese  individual  with  a  family  history  of  stroke,  genetic
redisposition  may  contribute  to  increased  arterial  stiffness
ather  than  shared  familial  lifestyle.
In  the  current  study,  we  could  not  ﬁnd  an  association
etween  a  family  history  of  ischaemic  heart  disease  and  ba-
WV.  There  are  few  reports  on  the  relationship  between
amily  history  of  ischaemic  heart  disease  and  ba-PWV.  A
revious  report  suggested  that  there  was  no  association
etween  aortic  PWV  and  a  family  history  of  myocardial
nfarction  in  asymptomatic  middle-aged  women  [29],  and
his  ﬁnding  is  concordant  with  our  result.  Given  that  acute
yocardial  infarction  is  a  weak  reﬂection  of  atherosclerotic
ascular  disease,  we  might  not  ﬁnd  an  association  between
 family  history  of  ischaemic  heart  disease  and  ba-PWV.
tudy limitations
ur  study  has  several  limitations.  First,  information  about
ge  at  time  of  ﬁrst  episode  and  subtypes  of  stroke  recorded
n  family  histories  of  diseases  was  lacking;  therefore,  we
ould  not  evaluate  the  speciﬁc  association  between  age  at
rst  episode  or  subtypes  of  stroke  in  family  histories  and
ncreased  ba-PWV.  Second,  information  about  the  family
istory  of  diseases  was  self-reported;  therefore,  unrecog-
ized  cases  may  have  existed.  However,  because  ischaemic
eart  disease  and  stroke  events  are  symptomatic,  there  may
nly  have  been  a  few  unrecognized  cases  of  these  events.
n  addition,  misclassiﬁed  self-reported  information  might
ttenuate  the  true  effects.  Third,  our  study  included  rela-
ively  few  subjects,  possibly  lowering  the  statistical  power.
inally,  as  all  of  our  subjects  were  Japanese,  our  results  may
ot  be  applicable  to  other  ethnic  populations.
onclusions
ur  study  demonstrates  that  a  family  history  of  stroke  is
otentially  associated  with  increased  ba-PWV,  independent
f  other  well-known  atherosclerotic  risk  factors,  including
ypertensive  elements,  in  both  sexes  in  the  Japanese  popu-
ation.  Further  large  studies,  including  detailed  information
bout  age  at  ﬁrst  episode  and  subtypes  of  stroke  in  family
istories,  will  be  needed.
[H.  Uemura  et  al.
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